ASML HOLDING 1 653.000 € (+3,51 %) 
MONCEY (FIN.) NOM. 121.000 € (-0,82 %) ICAPE HOLDING 9.500 € (+2,37 %) AXA 42.070 € (+0,41 %) PROSUS 34.500 € (-0,90 %) ABN AMRO BANK N.V. 41.950 € (+1,21 %) TELEPERFORMANCE 69.000 € (-2,90 %) 
UNILEVER 52.840 € (-0,02 %) MEDIANTECHNOLOGIES 3.230 € (-10,40 %) JCDECAUX 24.460 € (-0,89 %) GROUPE SFPI 1.800 € (-3,23 %) BIC 64.900 € (-0,15 %) CREDIT AGRICOLE 16.885 € (-0,21 %) CAPGEMINI 108.900 € (-2,85 %) THALES 222.700 € (-1,15 %) SOITEC 170.700 € (+7,66 %) 2CRSI 26.820 € (+0,68 %) STMICROELECTRONICS 50.340 € (+6,54 %) TIKEHAU CAPITAL 15.680 € (+0,51 %) ENGIE 22.780 € (+1,15 %) MAGNUM 15.448 € (+1,18 %) BE SEMICONDUCTOR 204.800 € (+7,00 %) SOCIETE GENERALE 66.300 € (+0,33 %) NN GROUP 76.680 € (+0,74 %) ING GROEP N.V. 30.685 € (+1,44 %) OVH 16.310 € (-1,21 %) PRODWAYS GROUP 0.514 € (+2,80 %) CLARIANE 3.218 € (-5,58 %) MICHELIN 33.020 € (-0,24 %) TOTALENERGIES 74.460 € (-0,07 %) SHELL PLC 42.400 € (+0,38 %) 
ARCELORMITTAL SA 57.280 € (+0,95 %) TECHNIP ENERGIES 28.040 € (-1,20 %) PHILIPS KON 21.270 € (+0,33 %) ASM INTERNATIONAL 944.800 € (+5,45 %) ALPES (COMPAGNIE) 16.800 € (-0,94 %) ARTMARKET COM 3.340 € (+9,51 %) STIF 18.990 € (-58,36 %) SMCP 5.585 € (-3,46 %) 
DSM FIRMENICH AG 96.160 € (+0,06 %) 
AEGON 7.580 € (+0,69 %) CEGEDIM 10.840 € (-1,99 %) DASSAULT AVIATION 282.000 € (-0,28 %) SEMCO TECHNOLOGIES 50.700 € (+3,68 %) 74SOFTWARE 37.000 € (-2,12 %) PHARMING GROUP 0.870 € (-1,76 %) ADP 107.500 € (+3,07 %) CARREFOUR 15.325 € (-2,08 %) ACCOR 44.200 € (+0,43 %) AMOEBA 0.316 € (-1,25 %) SANOFI 70.810 € (-3,13 %) COMPAGNIE ODET 1 002.000 € (-0,79 %) UV GERMI 2.350 € (-3,69 %) AKZO NOBEL 56.680 € (+2,24 %) HEXAOM 20.200 € (-2,88 %) BNP PARIBAS ACT.A 92.060 € (+0,57 %) 
MEXEDIA 3.000 € (-3,85 %) WOLTERS KLUWER 67.820 € (-1,19 %) CARMILA 14.280 € (-1,65 %) DBT 0.082 € (-12,39 %) |
02/10/2026 20:23
EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error findingEQS-Ad-hoc: Pentixapharm Holding AG / Key word(s): Other Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014
Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding Ad-hoc announcement pursuant to Article 17 MAR The German Federal Financial Supervisory Authority (Bafin) has concluded its financial reporting review of the consolidated financial statements of Pentixapharm Holding AG (ISIN DE000A40AEG0, WKN A40AEG) as of December 31, 2024, which the Company disclosed in its ad-hoc announcement of June 9, 2026, with the finding that the consolidated financial statements as of December 31, 2024 contain errors in certain respects. The findings relate to the matters the Company already described in its ad-hoc announcement of June 9, 2026. In particular, Bafin takes the view that intangible assets are overstated by EUR 34.7 million and the capital reserve is overstated by EUR 21.6 million. Of the EUR 34.7 million, EUR 21.6 million is attributable to carrying amounts derived from a purchase price allocation at the level of the former shareholder of Pentixapharm AG, and EUR 13.1 million is attributable to expenditures incurred from 2021 through 2024 for the PentixaFor development project that, in Bafin s view, did not meet the criteria for capitalization. In the Management Board’s assessment, the findings have no material effect on the Company’s operating business, liquidity, or business prospects. The guidance for fiscal year 2026 remains unaffected by this. The Management Board of Pentixapharm Holding AG has resolved not to seek legal remedies against the decision issued by Bafin.
October 02, 2026
Pentixapharm Holding AG, Berlin The Management Board Contact: ir@pentixapharm.com
End of Inside Information 02-Oct-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
2409820 02-Oct-2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière